Patients should have equal access to medication regardless of when they were prescribed. They should have put the mmpr on hold and allowed all patients to reapply if they wanted to. All that's going to happen now is LPS are going to put even less effort in to supplying quality medication with a consistent supply. It could all be gone after the trial so why bother sinking more money into a potentially failed business than they have to. I'm sure they will just do the bare minimum to maintain and wait to see the outcome.